Company / EPS (Diluted)
ATOSSA THERAPEUTICS, INC. EPS (Diluted) History
FY2012-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$8.31
FY2016
5-year range
-$8.31 / -$0.38
FY2012-FY2016
Trend
-1262.3%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) changed -1262% YoY in FY2016, a notable deviation from the 4-year average annual change of -332%.
Based on SEC 10-K filings.
-8.31 in FY2016.
Declined from $-0.70 to $-8.31 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2016, eps (diluted) decreased 1262.3% year-over-year.
- Peak eps (diluted) was recorded in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -15.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2016 | -$8.31 | -1262.3% |
| FY2015 | -$0.61 | +12.9% |
| FY2014 | -$0.70 | -70.7% |
| FY2013 | -$0.41 | -7.9% |
| FY2012 | -$0.38 | - |
As of FY2016 · SEC 10-K · Updated Jun 24, 2026